Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm

Summary
Pharmaceutical companies regularly encounter substantial headwinds. Among the most significant are patent cliffs -- when...
Pharmaceutical companies regularly encounter substantial headwinds. Among the most significant are patent cliffs -- when therapies lose patent exclusivity, inviting cheaper generic or biosimilar competition that erodes their market share.
Related Articles
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill
JNJ
PositiveNANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
JNJ
PositiveJ&J Painting Recognized with 2026 Consumer Choice Award for Painting Contractor in Waterloo
JNJ
Positive